ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Bristol Myers Squibb
The Senior Specialist provides aseptic process validation support for the Devens Cell Therapy Facility, executing aseptic simulations and qualifications, authoring validation documentation, and leading risk assessments. The role also manages change controls, supports investigations, and ensures cGMP compliance as a subject‑matter expert.
Headquarters
Lawrence Township, New Jersey, United States
Company Size
10001+ employees
Founded
1887
Bristol Myers Squibb is a global biopharmaceutical company that discovers, develops, and delivers prescription medicines for serious diseases, with a focus on oncology, hematology, immunology, cardiovascular, neuroscience, and other therapeutic areas. The company operates in the pharmaceutical and biotechnology industry, serving patients worldwide through research, development, manufacturing, and commercialization of innovative therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Bristol Myers Squibb.
27% below the average for this role
QA Validation Specialist - Cell and Gene Therapy
BioPharma Consulting JAD
Cell Therapy Biotechnologist
Lonza
Senior Manager, Cell Therapy Manufacturing
UPS
QA – Process Validation Supervisor
Sun Pharmaceutical Industries Limited
Aseptic Technician III
Zoetis
Associate II/III, Quality Control Environmental Monitoring
Artiva Biotherapeutics